{"url":"https://lda.senate.gov/api/v1/filings/8375403c-e53c-4ecd-b63d-bd8c6815d08e/","filing_uuid":"8375403c-e53c-4ecd-b63d-bd8c6815d08e","filing_type":"RR","filing_type_display":"Registration","filing_year":2019,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/8375403c-e53c-4ecd-b63d-bd8c6815d08e/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Frankie L. Trull","dt_posted":"2019-07-12T09:07:54-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"PO Box 2147","registrant_address_2":null,"registrant_different_address":null,"registrant_city":"Middleburg","registrant_state":"VA","registrant_zip":"20118","registrant":{"id":401105328,"url":"https://lda.senate.gov/api/v1/registrants/401105328/","house_registrant_id":null,"name":"BEACON STREET STRATEGIES, LLC","description":"Government Relations","address_1":"PO Box 2147","address_2":null,"address_3":null,"address_4":null,"city":"Middleburg","state":"VA","state_display":"Virginia","zip":"20118","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"FRANKIE L. TRULL","contact_telephone":"+1 202-270-9411","dt_updated":"2022-05-27T13:50:49.300927-04:00"},"client":{"id":203545,"url":"https://lda.senate.gov/api/v1/clients/203545/","client_id":12,"name":"RAPID MICRO BIOSYSTEMS, INC.","general_description":"Identifying microbial contaminants in manufacture of drugs, medical devices, etc.","client_government_entity":false,"client_self_select":null,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-07-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Development of improved technology to identify microbial contaminants in manufacture of drugs, medical devices and personal care products to insure public health and safety.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":70864,"prefix":null,"prefix_display":null,"first_name":"FRANKIE","nickname":null,"middle_name":"L","last_name":"TRULL","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Development of improved technology to identify microbial contaminants in manufacture of drugs, medical devices and personal care products to insure public health and safety.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":70864,"prefix":null,"prefix_display":null,"first_name":"FRANKIE","nickname":null,"middle_name":"L","last_name":"TRULL","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Development of improved technology to identify microbial contaminants in manufacture of drugs, medical devices and personal care products to insure public health and safety.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":70864,"prefix":null,"prefix_display":null,"first_name":"FRANKIE","nickname":null,"middle_name":"L","last_name":"TRULL","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}